Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 2Osteoradionecrosis 1Lymphedema 1Fibrosis 1Breast Neoplasms 1

Interventions

Manual Lymphatic Drainage 2Exercise 2Weights and Measures 1Ultrasonography 1Tocopherols 1Standard of Care 1Resistance Training 1Range of Motion, Articular 1Pravastatin 1Phenoxybenzamine 1Pharmaceutical Preparations 1Pentoxifylline 1Operative Blood Salvage 1Myofascial Release Therapy 1Mastectomy, Segmental 1Mastectomy 1Lymphoscintigraphy 1Low-Level Light Therapy 1Ketoprofen 1High-Energy Shock Waves 1Diffusion Tensor Imaging 1Control Groups 1Bupivacaine 1Body Mass Index 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Lymphedema × Pentoxifylline × Clear all
NCT06912763 2026-01-26

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

M.D. Anderson Cancer Center

Phase 2 Recruiting
250 enrolled
Head & Neck

Fibrosis, Head and Neck Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡